Reduction of supragingival plaque accumulations in institutionalized Down's syndrome patients by periodic treatment with topical kanamycin.
D000293:Adolescent; D002648:Child; D002986:Clinical Trials as Topic; D003773:Dental Plaque / Q000382:microbiology / Q000517:prevention & control*; D004314:Down Syndrome / Q000150:complications*; D004352:Drug Resistance, Microbial; D005260:Female; D005891:Gingivitis / Q000150:complications; D006801:Humans; D007612:Kanamycin / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D009909:Oral Health; D010919:Placebos
D010919:Placebos; D007612:Kanamycin